150 related articles for article (PubMed ID: 7214664)
1. Clinical trials of misonidazole in the United States.
Wasserman TH; Stetz J; Phillips TL
Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
[TBL] [Abstract][Full Text] [Related]
2. Radiation Therapy Oncology Group clinical trials with misonidazole.
Wasserman TH; Stetz J; Phillips TL
Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
[TBL] [Abstract][Full Text] [Related]
5. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
[No Abstract] [Full Text] [Related]
6. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials with hypoxic cell sensitizers-the European experience.
Dische S
Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
[No Abstract] [Full Text] [Related]
8. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
[TBL] [Abstract][Full Text] [Related]
10. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
11. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
[TBL] [Abstract][Full Text] [Related]
12. New side effect of the hypoxic cell sensitizer, misonidazole.
Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
[TBL] [Abstract][Full Text] [Related]
13. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Fazekas JT; Goodman RL; McLean CJ
Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
[No Abstract] [Full Text] [Related]
14. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
Leibel SA; Order SE; Rominger CJ; Asbell SO
Cancer Clin Trials; 1981; 4(3):285-93. PubMed ID: 6169464
[No Abstract] [Full Text] [Related]
15. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Bleehen NM
Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
Coleman CN; Halsey J; Cox RS; Hirst VK; Blaschke T; Howes AE; Wasserman TH; Urtasun RC; Pajak T; Hancock S
Cancer Res; 1987 Jan; 47(1):319-22. PubMed ID: 3024818
[TBL] [Abstract][Full Text] [Related]
17. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin, tumor response and neurotoxicity.
Moore JL; Paterson IC; Dawes PJ; Henk JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):361-4. PubMed ID: 7107352
[TBL] [Abstract][Full Text] [Related]
18. A national trial on the treatment of invasive bladder cancer.
Arnold EP; Bailey C; Burry AF; Bydder PV; Firth LA; Gowland S; Gray AJ; Mcllroy R
N Z Med J; 1981 Apr; 93(682):273-5. PubMed ID: 7019784
[TBL] [Abstract][Full Text] [Related]
19. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
20. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
Meoz RT; Spanos WJ; Doss L; Johnson R; Wasserman TH
Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]